HVTN 302

A phase 1, randomized, open-label clinical trial to evaluate the safety and immunogenicity of HIV trimer mRNA vaccines in healthy, HIV-uninfected adult participants.

Need additional information?

Full Name: (required)

Age:

Race:

Black or African American

Latino

Other

Phone: (required)

Email: (required)

Best time to contact:

Special contact information:

How did you hear about us?

Craigslist

Facebook

Flyer

Instagram/Twitter

Online

Participant referral

Word-of-mouth

Please indicate if you heard about us by any of these means:

Print Ad:

Community Meeting:

Special Event:

Other:

VSP